One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women.
A four-year study of 4,360 patients showed that post-menopausal women taking one of the thiazolidinediones were more likely to break a bone. The Therapeutic Goods Administration won't withdraw the drugs, but manufacturers are warning doctors about the newly identified risks.
- read the report [1] from the Sydney Morning Herald
Related Articles:
Avandia, Actos don't boost death risk. Report [2]
Actos on a good-news roll. Report [3]
Avandia risks back in the headlines. Report [4]
Australia bans Novartis' Prexige. Report [5]
Links:
[1] http://www.smh.com.au/news/National/Diabetes-drug-linked-to-fractures-risk/2007/10/04/1191091263085.html
[2] http://www.fiercepharma.com/story/avandia-actos-dont-boost-death-risk/2007-09-28
[3] http://www.fiercepharma.com/story/actos-good-news-roll/2007-09-21?utm_medium=rss&utm_source=rss
[4] http://www.fiercepharma.com/story/avandia-risks-back-in-the-headlines/2007-09-12?utm_medium=nl&utm_source=link
[5] http://www.fiercepharma.com/story/australia-bans-novartis-prexige/2007-08-13